Valuation: MedAvail Holdings, Inc.

Market Cap 7.25M 6.44M 6.01M 5.48M 10.33M 697M 10.43M 72.72M 28.18M 356M 27.21M 26.62M 1.14B P/E 2021
-1.04x
P/E 2022 -0.41x
Enterprise Value 2.88M 2.56M 2.39M 2.17M 4.1M 277M 4.14M 28.88M 11.19M 141M 10.8M 10.57M 454M EV / Sales 2021
1.74x
EV / Sales 2022 0.46x
Free-Float
100%
Yield 2021 *
-
Yield 2022 -
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 1.0E-6
0.05
3 years 0
Extreme 1.0E-6
7.49
5 years 0
Extreme 1.0E-6
178
10 years 0
Extreme 1.0E-6
1,039.5
Manager TitleAgeSince
Director of Finance/CFO 57 19/09/2021
Corporate Officer/Principal 45 17/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/23 Exercice

Chief Financial Officer

1,663 0.1030%
18/08/23 Free

Chief Executive Officer

250,000 0.3098%
18/08/23 Free

Chief Financial Officer

114,968 0.1425%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-100.00% 161
+0.69%-0.59%+28.28%+152.45% 123B
+1.94%+2.14%+24.92%+42.48% 97.45B
+2.88%+6.21%+119.59%+192.06% 65.48B
-0.11%+3.00%+34.24%+84.32% 60.3B
+1.05%+0.63%+5.36%+85.02% 58.24B
-0.85%+1.50%+46.81%+53.68% 35.94B
-0.23%+1.34%+32.14%+69.34% 29.97B
+0.04%+5.50%+57.65%+7.67% 29.28B
+1.09%-0.01%-9.63%+19.61% 29.52B
Average +0.65%+1.49%+33.94%+60.66% 52.88B
Weighted average by Cap. +0.97%+1.34%+38.11%+95.04%

Financials

2021 2022
Net sales 22.13M 19.66M 18.35M 16.73M 31.55M 2.13B 31.84M 222M 86.06M 1.09B 83.08M 81.28M 3.49B 43.11M 38.3M 35.75M 32.58M 61.45M 4.14B 62.03M 433M 168M 2.12B 162M 158M 6.8B
Net income -43.82M -38.93M -36.33M -33.12M -62.46M -4.21B -63.04M -440M -170M -2.15B -165M -161M -6.91B -47.62M -42.31M -39.49M -35.99M -67.88M -4.58B -68.51M -478M -185M -2.34B -179M -175M -7.51B
Net Debt -7.44M -6.61M -6.17M -5.63M -10.61M -715M -10.71M -74.69M -28.94M -366M -27.94M -27.33M -1.17B -4.37M -3.88M -3.62M -3.3M -6.23M -420M -6.29M -43.85M -16.99M -215M -16.4M -16.05M -689M
Logo MedAvail Holdings, Inc.
MedAvail Holdings, Inc. is a pharmacy technology and services company. The Company is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. It operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.
Employees
279
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. MYOS Stock